Jackie's life changed with a single phone call when her dermatologist called to tell her that the mole that she tried to ignore for months was melanoma. Learn how this journalist transformed into a melanoma advocate committed to raising awareness of the best melanoma.
Is AI the future of detecting melanoma early, when it is easiest to cure?
Brain metastases (mets) are a frequent and often deadly problem in patients with advanced melanoma. Nearly 40% of patients with metastatic melanoma have brain mets at diagnosis, with an average survival of only 4 months, highlighting a crucial need for treatments that can rid the brain of these tumors. Fortunately, MRA-funded researchers are making headway in understanding brain mets and how to best treat them.
We know that facing cancer requires enormous personal strength and that each person's inspiration is unique to them. That's why we're asking you to show how you harness your unique inner power to rise up against the disease by sharing a photo of you holding a sign that says #ReadyRaiseRise.
Applying AI to Melanoma Detection
MRA Applauds Latest Melanoma Drug Approval
New Report: Ten Years of Accelerating Cures: Highlights from the Melanoma Research Alliance 10th Annual Scientific Retreat.
Leveraged Finance Industry Raises Record $2 million for Life-Saving Melanoma Research
New Grants Totaling $2.6 Million Fund Work to Reduce Immunotherapy Side Effects
I've lost my password